Houstek Josef, Kmoch Stanislav, Zeman Jirí
Department of Bioenergetics, Academy of Sciences of the Czech Republic, Vídenská 1083, 142 20 Prague 4-Krc, Czech Republic.
Biochim Biophys Acta. 2009 May;1787(5):529-32. doi: 10.1016/j.bbabio.2008.11.013. Epub 2008 Dec 6.
An increasing number of patients with nuclear genetic defects of mitochondrial ATP synthase have been identified in recent years. They are characterized by early onset, lactic acidosis, 3-methylglutaconic aciduria, hypertrophic cardiomyopathy and encephalopathy and most cases have a fatal outcome. Patient tissues show isolated defect of the ATP synthase complex and its content decreases to > or =30% of normal due to altered enzyme biosynthesis and assembly. Gene mapping and complementation studies have identified mutations in TMEM70 gene encoding a 30kD mitochondrial protein of unknown function as the cause of the disease. An altered synthesis of this new ancillary factor in ATP synthase biogenesis was found in most of the known patients with decreased ATP synthase content. As revealed by phylogenetic analysis, TMEM70 is specific for higher eukaryotes.
近年来,已鉴定出越来越多患有线粒体ATP合酶核基因缺陷的患者。他们的特征是发病早、乳酸酸中毒、3 - 甲基戊二酸尿症、肥厚性心肌病和脑病,大多数病例预后不良。患者组织显示ATP合酶复合体存在孤立缺陷,由于酶生物合成和组装改变,其含量降至正常的≥30%。基因定位和互补研究已确定,编码一种功能未知的30kD线粒体蛋白的TMEM70基因突变是该疾病的病因。在大多数已知的ATP合酶含量降低的患者中,发现这种参与ATP合酶生物合成的新辅助因子的合成发生了改变。系统发育分析表明,TMEM70是高等真核生物所特有的。